Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1300
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00424515 | Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma | ||
| NCT04482244 | RCT of CBD for Anxiety in Advanced Breast Cancer | ||
| NCT00003058 | Troglitazone in Treating Patients With Liposarcoma | ||
| NCT00686855 | Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease | ||
| NCT00630344 | RAD001 and Bicalutamide for Androgen Independent Prostate Cancer | ||
| NCT03414658 | The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer | ||
| NCT02852655 | A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma | ||
| NCT03534323 | Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS | ||
| NCT04703426 | Sargramostim (GM-CSF) + PD-1 | ||
| NCT03152318 | A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 | ||
| NCT00148720 | Capecitabine in Women With Operable Breast Cancer | ||
| NCT00976248 | Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia | ||
| NCT03367247 | BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal | ||
| NCT00165490 | Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer | ||
| NCT01222572 | Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer | ||
| NCT00631072 | In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer | ||
| NCT05740839 | High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study | ||
| NCT03485547 | Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | ||
| NCT00098514 | Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors | ||
| NCT00936858 | RAD001 for Patients With Radioiodine Refractory Thyroid Cancer | ||
| NCT04584255 | Niraparib + Dostarlimab In BRCA Mutated Breast Cancer | ||
| NCT00058487 | Epirubicin and Thalidomide in Treating Patients With Liver Cancer | ||
| NCT00657267 | Dose-Intense Temozolomide in Recurrent Glioblastoma | ||
| NCT03660228 | Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS | ||
| NCT04166487 | Plasma-Adapted First-Line Pembro In NSCLC | ||
| NCT00142116 | Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia | ||
| NCT05342584 | Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS | ||
| NCT04906200 | Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors | ||
| NCT00153907 | Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer | ||
| NCT03609177 | Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly | ||
| NCT04608487 | Axi-cel in CNS Lymphoma | ||
| NCT04843904 | Safe Accelerated Venetoclax Escalation in CLL | ||
| NCT02337491 | Pembrolizumab +/- Bevacizumab for Recurrent GBM | ||
| NCT04908852 | Feasibility Pilot Exploring Variability in Biomarkers and PROs in AML | ||
| NCT00142181 | Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia | ||
| NCT00004070 | Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer | ||
| NCT06335745 | PediCARE Health Equity Intervention in High-Risk Neuroblastoma | ||
| NCT06502483 | PRISM for Depression and Anxiety in Young Adults With Cancer | ||
| NCT06582914 | Lynch Syndrome Integrative Epidemiology and Genetics | ||
| NCT00006107 | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | ||
| NCT02026934 | CliniMACS® CD34+ Reagent System for Expanded Access Use | ||
| NCT04572763 | Copanlisib Plus Venetoclax in R/R DLBCL | ||
| NCT07439211 | Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia | ||
| NCT04802187 | Implementation of COVID-19 Testing Strategies in Community Health Centers | ||
| NCT05210101 | A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals | ||
| NCT02046811 | Reducing Skin Cancer Risk in Childhood Cancer Survivors | ||
| NCT06318871 | Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma | ||
| NCT03858712 | EHR-embedded OCDT in Breast or GI Cancer | ||
| NCT01958112 | GSK1120212+GSK2141795 for Cervical Cancer | ||
| NCT00694330 | Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor |
